Get the Stockscreener App
42.03
3.43%
1.2209
Phibro Animal Health Corp stock is traded at $42.03, with a volume of 97,339.
It is up +3.43% in the last 24 hours and up +1.83% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$40.81
Open:
$40.8
24h Volume:
97,339
Relative Volume:
0.30
Market Cap:
$859.82M
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
113.60
EPS:
0.37
Net Cash Flow:
$37.02M
1W Performance:
-6.41%
1M Performance:
+1.83%
6M Performance:
+81.55%
1Y Performance:
+77.65%
1-Day Range:
$40.41
$42.22
1-Week Range:
$40.41
$46.27
52-Week Range:
$16.16
$46.42
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
42.05 | 1.65B | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
121.50 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.885 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.30 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
473.07 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
Zacks.com featured highlights include Phibro Animal Health, Astronics, CommScope and Heritage Insurance - Yahoo Finance
Is Phibro Animal Health Corporation (PB8) stock a top hedge fund pickRecession Risk & Weekly High Potential Alerts - newser.com
Phibro (PAHC) Upgraded to Strong Buy: Here's What You Should Know - Nasdaq
New Strong Buy Stocks for Nov. 20: CMC, BCAL, and More - sharewise.com
How Phibro Animal Health Corporation (PB8) stock gains from tech spendingBreakout Watch & Real-Time Chart Pattern Alerts - newser.com
Will Phibro Animal Health Corporation (PB8) stock rise with strong economyMarket Performance Recap & Stock Portfolio Risk Management - newser.com
How Phibro Animal Health Corporation (PB8) stock reacts to monetary easingJuly 2025 PreEarnings & Long-Term Capital Growth Strategies - newser.com
Applying chart zones and confluence areas to Phibro Animal Health CorporationQuarterly Market Review & Daily Profit Maximizing Trade Tips - newser.com
Chart overlay techniques for tracking Phibro Animal Health CorporationWeekly Trade Recap & AI Powered Market Entry Ideas - newser.com
Phibro Animal Health Corporation stock prediction for this weekPortfolio Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Why KALU stock attracts strong analyst attention - newser.com
Will Phibro Animal Health Corporation (PB8) stock outperform global peersMarket Trend Report & Fast Exit Strategy with Risk Control - newser.com
Is Phibro Animal Health Corporation stock overvalued by current metricsRisk Management & Real-Time Market Trend Scan - newser.com
Published on: 2025-11-19 00:02:14 - newser.com
Phibro Animal Health (PAHC) director sells $466k in shares By Investing.com - Investing.com Nigeria
How to integrate Phibro Animal Health Corporation into portfolio analysis toolsShare Buyback & Accurate Entry and Exit Point Alerts - newser.com
Phibro Animal Health (PAHC) director sells $466k in shares - Investing.com India
[Form 4] PHIBRO ANIMAL HEALTH CORP Insider Trading Activity - Stock Titan
Chmn Bendheim Sells 10,560 ($466.6K) Of Phibro Animal Health Corp [PAHC] - TradingView
Phibro Animal Health Corporatio (PAHC) Stock Forecasts - Yahoo Finance
Published on: 2025-11-18 00:56:21 - newser.com
Wall Street Has a Positive Outlook on Phibro Animal Health Corporation (PAHC) Since Q1 2026 Results - Finviz
Don't Overlook Phibro (PAHC) International Revenue Trends While Assessing the Stock - Yahoo Finance
Will Phibro Animal Health Corporation (PB8) stock remain on Wall Street radarRisk Management & Weekly Setup with ROI Potential - newser.com
Should I buy Phibro Animal Health Corporation (PB8) stock before earnings seasonBuy Signal & Free Daily Entry Point Trade Alerts - newser.com
Can Phibro Animal Health Corporation (PB8) stock attract analyst upgradesTreasury Yields & AI Powered Market Entry Ideas - newser.com
10 Hottest Small Cap Stocks to Buy Now - Insider Monkey
Phibro Animal Health (PAHC) Q1 Earnings and Revenues Top Estimates - MSN
BFI Co. sells Phibro Animal Health (PAHC) shares worth $1.36 million By Investing.com - Investing.com Canada
BFI Co. sells Phibro Animal Health (PAHC) shares worth $1.36 million - Investing.com Nigeria
Chmn Bendheim Sells 30,337 ($1.4M) Of Phibro Animal Health Corp [PAHC] - TradingView
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Phibro Animal Health Corp Stock (PAHC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK | President and CEO |
Nov 18 '25 |
Sale |
43.82 |
5,280 |
231,377 |
49,680 |
| BENDHEIM JACK | President and CEO |
Nov 12 '25 |
Sale |
45.23 |
21,536 |
973,976 |
14,041 |
| BENDHEIM JACK | President and CEO |
Nov 13 '25 |
Sale |
44.47 |
8,801 |
391,417 |
5,240 |
| BENDHEIM JACK | President and CEO |
Nov 10 '25 |
Sale |
45.29 |
38,303 |
1,734,767 |
20,577 |
| BENDHEIM JACK | President and CEO |
Nov 07 '25 |
Sale |
42.86 |
3,520 |
150,851 |
58,880 |
| BENDHEIM JACK | President and CEO |
Nov 04 '25 |
Sale |
43.10 |
3,520 |
151,703 |
65,920 |
| BENDHEIM JACK | President and CEO |
Nov 05 '25 |
Sale |
41.21 |
3,520 |
145,075 |
62,400 |
| BENDHEIM JACK | President and CEO |
Oct 29 '25 |
Sale |
41.66 |
3,520 |
146,627 |
47,960 |
| BENDHEIM JACK | President and CEO |
Oct 28 '25 |
Sale |
41.56 |
3,520 |
146,277 |
51,480 |
| BENDHEIM JACK | President and CEO |
Oct 30 '25 |
Sale |
41.07 |
3,520 |
144,582 |
44,440 |
2.50%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):